Stockscreener 앱 받기
15.27
1.32%
-0.2061
전일 마감가:
$15.48
열려 있는:
$15.49
하루 거래량:
2.17M
Relative Volume:
0.65
시가총액:
$3.65B
수익:
$474.17M
순이익/손실:
$208.93M
주가수익비율:
17.98
EPS:
0.8493
순현금흐름:
$65.61M
1주 성능:
-2.08%
1개월 성능:
+4.20%
6개월 성능:
-35.06%
1년 성능:
-21.14%
1일 변동 폭
$15.10
$15.68
1주일 범위
$15.07
$15.76
52주 변동 폭
$13.82
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
명칭
Adma Biologics Inc
전화
(201) 478-5552
주소
C/O ADMA BIOLOGICS, INC., RAMSEY
ADMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
15.29 | 3.69B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.48 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
639.93 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.94 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
823.90 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.96 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-19 | 재개 | Raymond James | Strong Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2021-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 개시 | Jefferies | Buy |
| 2019-04-15 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-07 | 재개 | H.C. Wainwright | Buy |
| 2017-12-11 | 재확인 | Maxim Group | Buy |
| 2017-11-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | 업그레이드 | Maxim Group | Hold → Buy |
| 2016-08-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2016-07-25 | 재확인 | Maxim Group | Buy |
| 2015-05-13 | 재확인 | Maxim Group | Buy |
| 2014-12-08 | 개시 | Oppenheimer | Outperform |
| 2014-12-01 | 재확인 | Maxim Group | Buy |
모두보기
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
Y Intercept Hong Kong Ltd Buys 38,809 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Risk adjusted return profile for ADMA Biologics Inc. analyzedWatch List & High Accuracy Investment Entry Signals - newser.com
Applying Wyckoff theory to ADMA Biologics Inc. stockJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
ADMA Biologics (ADMA): Evaluating Valuation After Major Institutional Exit by Palisades Investment Partners - Yahoo Finance
Can ADMA Biologics Inc. stock attract ESG capital inflowsGap Down & Real-Time Stock Entry Alerts - newser.com
ADMA Biologics (ADMA) to Release Quarterly Earnings on Thursday - MarketBeat
Will ADMA Biologics Inc. stock keep outperforming rivalsTreasury Yields & Weekly Hot Stock Watchlists - newser.com
ADMA Biologics Inc Stock Analysis and ForecastSector Performance Drivers & Free Take Advantage Of Momentum - earlytimes.in
Will ADMA Biologics Inc. stock continue dividend increasesTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
Building trade automation scripts for ADMA Biologics Inc.Trade Performance Summary & Weekly Top Stock Performers List - newser.com
ADMA Biologics Inc (ADMA) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - sharewise.com
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times
ADMA Biologics (Nasdaq: ADMA) sets Nov. 5 call at 4:30 p.m. ET for third-quarter results - Stock Titan
Is ADMA Biologics Stock Trading At A Bargain? - Trefis
Signal Recap: Why ADMA Biologics Inc. stock is a must watch in 2025Earnings Performance Report & Verified Swing Trading Watchlist - fcp.pa.gov.br
Peregrine Capital Management LLC Acquires 53,515 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Will ADMA Biologics Inc. stock outperform international peersExit Point & Risk Controlled Swing Trade Alerts - fcp.pa.gov.br
Risk Check: Why ADMA Biologics Inc. stock is a must watch in 2025 - Fundação Cultural do Pará
Analyst Upgrade: Will ADMA Biologics Inc. stock continue dividend increasesPortfolio Value Summary & Real-Time Volume Spike Alerts - fcp.pa.gov.br
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - sharewise.com
ADMA Biologics Adjusts Valuation Amid Strong Financial Performance and Growth Metrics - Markets Mojo
Is ADMA Biologics Inc a good long term investmentEarnings Date Calendar & Low Entry Investment Ideas - earlytimes.in
ADMA Biologics (ADMA): Assessing Valuation After Q2 Earnings Miss and Upgraded Financial Outlook - Sahm
Comparing ADMA Biologics Inc. in custom built stock radarsTrade Exit Summary & Trade Opportunity Analysis - newser.com
Allianz Asset Management GmbH Buys 33,894 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Adma Biologics Inc (ADMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
1.56%
자본화:
|
볼륨(24시간):